Adverse Outcomes Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Infection in Vaccinated Residents of a Long-Term Care Home, Ontario, Canada
Clin Infect Dis. 2022 Mar 1;74(4):751-752.
doi: 10.1093/cid/ciab523.